|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| (Increase) reduction in carrying amount of right-of-use assets | |||||
| (Recoveries of) provision for losses on accounts receivable | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Loss on disposal of property, plant and equipment | |||||
| Accrued interest earned on marketable securities | |||||
| Non-cash restructuring charges | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets, net | |||||
| Accounts payable | |||||
| Accrued and other long-term liabilities | |||||
| Deferred revenues | |||||
| Lease liabilities | |||||
| Non-current income taxes payable | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from sale of fixed assets | |||||
| Purchases of property, plant and equipment | |||||
| Acquisition of intangible assets and capitalization of patents | |||||
| Purchase of marketable securities | |||||
| Proceeds from maturities and sales of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments on term loan, debt and financing leases | |||||
| Payment of contingent consideration related to acquisition | |||||
| Proceeds from public offering, net of offering costs | |||||
| Proceeds from line of credit | |||||
| Proceeds from employee stock plan purchases | |||||
| Proceeds from stock option exercises | |||||
| Tax payments related to stock award issuances | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Operating cash outflows from operating leases | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Accrued purchases of property, equipment and patents | |||||
| Reconciliation of cash, cash equivalents, and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...